Chesley Taft & Associates LLC Raises Position in HealthEquity, Inc. $HQY

by · The Markets Daily

Chesley Taft & Associates LLC lifted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 19.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,045 shares of the company’s stock after purchasing an additional 2,423 shares during the period. Chesley Taft & Associates LLC’s holdings in HealthEquity were worth $1,576,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Ieq Capital LLC lifted its holdings in shares of HealthEquity by 4.4% during the 1st quarter. Ieq Capital LLC now owns 2,945 shares of the company’s stock worth $260,000 after acquiring an additional 123 shares during the last quarter. Xponance Inc. lifted its holdings in shares of HealthEquity by 1.1% during the 1st quarter. Xponance Inc. now owns 12,412 shares of the company’s stock worth $1,097,000 after acquiring an additional 136 shares during the last quarter. Fifth Third Bancorp lifted its holdings in shares of HealthEquity by 17.5% during the 1st quarter. Fifth Third Bancorp now owns 955 shares of the company’s stock worth $84,000 after acquiring an additional 142 shares during the last quarter. AlphaQ Advisors LLC lifted its holdings in shares of HealthEquity by 5.1% during the 1st quarter. AlphaQ Advisors LLC now owns 3,430 shares of the company’s stock worth $303,000 after acquiring an additional 165 shares during the last quarter. Finally, State of Wyoming lifted its holdings in shares of HealthEquity by 2.9% during the 1st quarter. State of Wyoming now owns 5,915 shares of the company’s stock worth $523,000 after acquiring an additional 169 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on HQY. JMP Securities lifted their price objective on shares of HealthEquity from $110.00 to $117.00 and gave the stock a “market outperform” rating in a report on Wednesday, June 4th. The Goldman Sachs Group boosted their price target on shares of HealthEquity from $94.00 to $104.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 4th. Bank of America boosted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock a “buy” rating in a research note on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of HealthEquity from $98.00 to $115.00 and gave the stock a “buy” rating in a research note on Thursday, June 5th. Finally, Barrington Research reissued an “outperform” rating and issued a $125.00 price target on shares of HealthEquity in a research note on Friday, August 29th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $119.77.

Check Out Our Latest Stock Report on HealthEquity

Insiders Place Their Bets

In related news, EVP Michael Henry Fiore sold 1,794 shares of the firm’s stock in a transaction on Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the completion of the transaction, the executive vice president directly owned 53,225 shares of the company’s stock, valued at approximately $5,414,579.25. This trade represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.50% of the company’s stock.

HealthEquity Stock Performance

HQY opened at $92.28 on Thursday. The stock has a market capitalization of $7.95 billion, a price-to-earnings ratio of 55.93, a PEG ratio of 1.31 and a beta of 0.50. The company has a fifty day moving average of $92.90 and a 200 day moving average of $94.19. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23.

HealthEquity Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Read More

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).